FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892451788> ?p ?o ?g. }

• W2892451788 endingPage "2436" @default.
• W2892451788 startingPage "2430" @default.
• W2892451788 abstract "Background and Purpose— Patients with premorbid disability, generally defined as modified Rankin Scale (mRS) score ≥2, are often excluded from trials of acute stroke therapies. However, increased disability in such patients will adversely affect long-term outcomes if treatments are withheld in routine practice. We assessed the extent to which increased disability poststroke influences 5-year mortality, institutionalization, and costs in premorbidly disabled patients. Methods— In a population-based, prospective cohort of patients with ischemic stroke (OXVASC [Oxford Vascular Study], 2002–2014), we tracked mortality, institutionalization, and healthcare/social-care costs during follow-up. We compared 5-year mortality and poststroke institutionalization (Cox regressions) and 5-year healthcare/social-care costs (generalized linear model) in 3-month survivors with premorbid mRS of 2 to 4 (excluding extreme disability, mRS=5), based on the degree of change in mRS(ΔmRS) from prestroke to 3 months poststroke, adjusting analyses for age/sex/initial National Institutes of Health Stroke Scale. Results— Among 1607 patients, 530 (33.0%) had premorbid mRS of 2 to 4. Only 2 premorbidly disabled patients received thrombolysis, but 421 (79.4%) were alive at 3 months. ΔmRS was independently associated with 5-year mortality/institutionalization (adjusted hazard ratio for ΔmRS=1 versus 0: 1.59; 95% CI, 1.20–2.11; ΔmRS=2: 2.39; 95% CI, 1.62–3.53; ΔmRS=3: 4.12; 95% CI, 1.98–8.60; P <0.001) and costs (margin for ΔmRS ≥2 versus 0: $30 011, 95% CI, $4222–55 801; P =0.023). Results were similar on examining patients with premorbid mRS of 2, 3, and 4 separately (eg, 5-year mortality/institutionalization adjusted hazard ratio for premorbid mRS=3 with ΔmRS=1 versus 0: 1.60; 95% CI, 1.06–2.42; P =0.027; ΔmRS=2: 3.20; 95% CI, 1.85–5.54; P <0.001). Conclusions— Patients with stroke with premorbid disability have higher mortality, institutionalization, and costs if they accumulate additional disability because of the stroke. These findings highlight the long-term outcomes expected if acute interventions are routinely withheld in patients with mild-moderate premorbid disability and suggest that trials/registries should include such patients." @default.
• W2892451788 created "2018-10-05" @default.
• W2892451788 creator A5018531683 @default.
• W2892451788 creator A5027568070 @default.
• W2892451788 creator A5036990987 @default.
• W2892451788 creator A5069738985 @default.
• W2892451788 date "2018-10-01" @default.
• W2892451788 modified "2023-10-14" @default.
• W2892451788 title "Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability" @default.
• W2892451788 cites W1564067244 @default.
• W2892451788 cites W1676366316 @default.
• W2892451788 cites W1975073117 @default.
• W2892451788 cites W1976873809 @default.
• W2892451788 cites W2000006102 @default.
• W2892451788 cites W2017206163 @default.
• W2892451788 cites W2037218783 @default.
• W2892451788 cites W2054589683 @default.
• W2892451788 cites W2058948365 @default.
• W2892451788 cites W2059570264 @default.
• W2892451788 cites W2069350582 @default.
• W2892451788 cites W2087358835 @default.
• W2892451788 cites W2102447759 @default.
• W2892451788 cites W2104470915 @default.
• W2892451788 cites W2108116414 @default.
• W2892451788 cites W2113333153 @default.
• W2892451788 cites W2116228592 @default.
• W2892451788 cites W2127272421 @default.
• W2892451788 cites W2128359271 @default.
• W2892451788 cites W2130386049 @default.
• W2892451788 cites W2133776884 @default.
• W2892451788 cites W2138114612 @default.
• W2892451788 cites W2139750291 @default.
• W2892451788 cites W2141842749 @default.
• W2892451788 cites W2157251388 @default.
• W2892451788 cites W2159233098 @default.
• W2892451788 cites W2161910408 @default.
• W2892451788 cites W2165568749 @default.
• W2892451788 cites W2171165037 @default.
• W2892451788 cites W2203834727 @default.
• W2892451788 cites W2215914629 @default.
• W2892451788 cites W2252447555 @default.
• W2892451788 cites W2277258071 @default.
• W2892451788 cites W2488449467 @default.
• W2892451788 cites W2506934626 @default.
• W2892451788 cites W2624587018 @default.
• W2892451788 cites W2626748500 @default.
• W2892451788 cites W4233542906 @default.
• W2892451788 cites W4255683973 @default.
• W2892451788 doi "https://doi.org/10.1161/strokeaha.118.022416" @default.
• W2892451788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6159688" @default.
• W2892451788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30355105" @default.
• W2892451788 hasPublicationYear "2018" @default.
• W2892451788 type Work @default.
• W2892451788 sameAs 2892451788 @default.
• W2892451788 citedByCount "43" @default.
• W2892451788 countsByYear W28924517882019 @default.
• W2892451788 countsByYear W28924517882020 @default.
• W2892451788 countsByYear W28924517882021 @default.
• W2892451788 countsByYear W28924517882022 @default.
• W2892451788 countsByYear W28924517882023 @default.
• W2892451788 crossrefType "journal-article" @default.
• W2892451788 hasAuthorship W2892451788A5018531683 @default.
• W2892451788 hasAuthorship W2892451788A5027568070 @default.
• W2892451788 hasAuthorship W2892451788A5036990987 @default.
• W2892451788 hasAuthorship W2892451788A5069738985 @default.
• W2892451788 hasBestOaLocation W28924517881 @default.
• W2892451788 hasConcept C118552586 @default.
• W2892451788 hasConcept C126322002 @default.
• W2892451788 hasConcept C127413603 @default.
• W2892451788 hasConcept C164429055 @default.
• W2892451788 hasConcept C1862650 @default.
• W2892451788 hasConcept C207103383 @default.
• W2892451788 hasConcept C2779581417 @default.
• W2892451788 hasConcept C2780289447 @default.
• W2892451788 hasConcept C2780645631 @default.
• W2892451788 hasConcept C2780931571 @default.
• W2892451788 hasConcept C2908647359 @default.
• W2892451788 hasConcept C3020199598 @default.
• W2892451788 hasConcept C44249647 @default.
• W2892451788 hasConcept C500558357 @default.
• W2892451788 hasConcept C50382708 @default.
• W2892451788 hasConcept C541997718 @default.
• W2892451788 hasConcept C71924100 @default.
• W2892451788 hasConcept C72563966 @default.
• W2892451788 hasConcept C78519656 @default.
• W2892451788 hasConcept C99454951 @default.
• W2892451788 hasConceptScore W2892451788C118552586 @default.
• W2892451788 hasConceptScore W2892451788C126322002 @default.
• W2892451788 hasConceptScore W2892451788C127413603 @default.
• W2892451788 hasConceptScore W2892451788C164429055 @default.
• W2892451788 hasConceptScore W2892451788C1862650 @default.
• W2892451788 hasConceptScore W2892451788C207103383 @default.
• W2892451788 hasConceptScore W2892451788C2779581417 @default.
• W2892451788 hasConceptScore W2892451788C2780289447 @default.
• W2892451788 hasConceptScore W2892451788C2780645631 @default.
• W2892451788 hasConceptScore W2892451788C2780931571 @default.
• W2892451788 hasConceptScore W2892451788C2908647359 @default.
• W2892451788 hasConceptScore W2892451788C3020199598 @default.

• next